Reuters - Video

Edition: US | UK | IN | CN | JP

video Health Watch

Amgen drug stops heart attacks but fails to woo investors

Friday, March 17, 2017 - 01:31

Amgen proved in a large-scale clinical trial that it's Repatha drug lowers the risk of heart attacks and strokes, but Wall Street still was unhappy with the results.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Amgen drug stops heart attacks but fails to woo investors

Friday, March 17, 2017 - 01:31